Financial Services
Live Price
Offline$13.85
+0.00% today
1Y Change
+11.87%
Window
Jun 23, 2025 → Jun 16, 2026
Coverage: 253 bars · Jun 23, 2025 → Jun 16, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
The People's Insurance Company (Group) of China Limited (PINXY) is a Financial Services stock with a market cap of $317.53B and listed on OTC. The stock last traded around $13.85 and up 11.9% across the available one-year price window (Jun 23, 2025 → Jun 16, 2026). Baseline metrics include revenue growth of +3.9%, EPS growth of +9.5%, a dividend yield of 2.7%. What stands out right now is revenue +3.9%, EPS +9.5%, free cash flow +57.7% with operating margin 10.0% and ROIC 2.6%. The dividend matters to the case here, with a current yield around 2.7%. Valuation is more restrained than many high-expectation growth names at P/E 7.5 and price/sales 0.5. Overall, the current profile looks closer to a income-oriented value setup than a generic broad-market placeholder. Stock Foundry combines PINXY price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Financial Services peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
PINXY
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
PINXY Max Drawdown
-31.44%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for PINXY and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$592.0B
+24.6% YoY
FY Net Income
$21.5B
-15.3% YoY
Free Cash Flow
$110.3B
+69.6% YoY
Revenue Growth
+3.9%
EPS Growth
+9.5%
Gross Margin
100.0%
Net Margin
6.5%
Income statement
CNY
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 622.1B | 598.8B | 530.2B | 475.1B | 592.0B |
| Gross Profit | 622.1B | 653.2B | 577.7B | 469.9B | 539.7B |
| Operating Income | 71.9B | 69.2B | 33.6B | 42.7B | 35.6B |
| EBITDA | 80.1B | 77.5B | 42.1B | 52.9B | 45.9B |
| Net Income | 44.9B | 42.2B | 22.3B | 25.4B | 21.5B |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
CNY
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Cash & Equivalents | 73.6B | 24.9B | 20.4B | 21.4B | 21.8B |
| Total Assets | 2028.9B | 1766.3B | 1556.7B | 1509.1B | 1376.9B |
| Total Liabilities | 1608.1B | 1398.9B | 1223.8B | 1208.2B | 1080.0B |
| Shareholder Equity | 309.4B | 268.9B | 243.2B | 221.8B | 219.3B |
| Total Debt | 224.6B | 52.6B | 40.9B | 46.2B | 47.4B |
| Net Debt | 151.0B | 27.7B | 18.2B | 24.8B | 25.6B |
Cash flow positioning
Latest Full Year
Operating Cash Flow
72.7B
+1.5% YoY
Capital Expenditures
37.6B
+672.0% YoY
Free Cash Flow
110.3B
+69.6% YoY
Key ratios
Gross Margin
100.0%
Operating Margin
10.0%
Net Margin
6.5%
ROE
13.9%
Debt / Equity
0.62x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.